Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
BMC Medicine
|
June 15, 2019
Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
P C D Bank, J J Swen, H J Guchelaar
Journal of Gastrointestinal Cancer
|
December 28, 2016
Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil
Catc Lunenburg, J J Swen, H-J Guchelaar, et al.
Annual Review of Pharmacology and Toxicology
|
September 30, 2024
Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation
R Mosch, M van der Lee, H J Guchelaar, et al.
Clinical Pharmacokinetics
|
May 31, 2013
The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs
N van Leeuwen, J J Swen, H-J Guchelaar, et al.
Clinical Pharmacology and Therapeutics
|
January 23, 2014
Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing
H-J Guchelaar, H Gelderblom, T van der Straaten, et al.
Drug Discovery Today
|
April 22, 2014
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics
M H ten Brink, J Zwaveling, J J Swen, et al.
Clinical Pharmacology and Therapeutics
|
May 28, 2013
Pharmacogenetics in transplant patients: mind the mix
M H Ten Brink, T van der Straaten, H Bouwsma, et al.
European Journal of Clinical Pharmacology
|
August 30, 2017
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
A B Sanchez Spitman, D J A R Moes, H Gelderblom, et al.
Scientific Reports
|
January 12, 2021
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
A B Sanchez-Spitman, J J Swen, V O Dezentjé, et al.
Clinical Pharmacology and Therapeutics
|
August 31, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
K E Caudle, C F Thorn, T E Klein, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
BMC Medicine
|
June 15, 2019
Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
P C D Bank, J J Swen, H J Guchelaar
Journal of Gastrointestinal Cancer
|
December 28, 2016
Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil
Catc Lunenburg, J J Swen, H-J Guchelaar, et al.
Annual Review of Pharmacology and Toxicology
|
September 30, 2024
Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation
R Mosch, M van der Lee, H J Guchelaar, et al.
Clinical Pharmacokinetics
|
May 31, 2013
The role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs
N van Leeuwen, J J Swen, H-J Guchelaar, et al.
Clinical Pharmacology and Therapeutics
|
January 23, 2014
Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing
H-J Guchelaar, H Gelderblom, T van der Straaten, et al.
Drug Discovery Today
|
April 22, 2014
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics
M H ten Brink, J Zwaveling, J J Swen, et al.
Clinical Pharmacology and Therapeutics
|
May 28, 2013
Pharmacogenetics in transplant patients: mind the mix
M H Ten Brink, T van der Straaten, H Bouwsma, et al.
European Journal of Clinical Pharmacology
|
August 30, 2017
Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism
A B Sanchez Spitman, D J A R Moes, H Gelderblom, et al.
Scientific Reports
|
January 12, 2021
Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse
A B Sanchez-Spitman, J J Swen, V O Dezentjé, et al.
Clinical Pharmacology and Therapeutics
|
August 31, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
K E Caudle, C F Thorn, T E Klein, et al.
Page
of 4